Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Energy Capital Partners, and Simpson Thacher & Bartlett advised Bridgepoint on the deal. J.P. Morgan Cazenove and Morgan Stanley served as lead...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised SLR, while Fried, Frank, Harris, Shriver & Jacobson advised Petershill and HPC on the deal. SLR Capital Partners, LLC (“SLR”), a boutique...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Thompson Street Capital Partners, while Fried, Frank, Harris, Shriver & Jacobson advised on the deal. Thompson Street Capital Partners announced a strategic...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Waterton, while Fried, Frank, Harris, Shriver & Jacobson advised Almanac on the deal. Waterton, a national real estate investor and operator, closed...
You must be a Standard 1 Year member to access this content.
